Literature DB >> 22886234

Early and marked up-regulation of TNF-α in acute respiratory distress syndrome after cardiopulmonary bypass.

Tao Li1, Nanfu Luo, Lei Du, Jin Liu, Lina Gong, Jing Zhou.   

Abstract

Despite the technique of cardiopulmonary bypass (CPB) improved the development of modern cardiac surgery, many factors during CPB have been reported to induce acute respiratory distress syndrome (ARDS). The present study was to investigate which pro-inflammatory factors involved in the early phase of ARDS. Ten patients underwent valve replacement surgery with or without ARDS were enrolled for analysis of pulmonary function and inflammatory factors release including white blood cell (WBC), neutrophils, CD11b, CD18, interleukin (IL)-8 and tumor necrosis factor-α (TNF-α). The results demonstrated that the ratio of arterial oxygen tension/fraction of inspire oxygen (PaO(2)/FiO(2)) was greatly reduced in ARDS patients, but only the release of TNF-α was significantly increased, which was reversely correlated to the values of PaO(2)/FiO(2). Also, the count of neutrophils adhesive to pulmonary endothelial cells was significantly increased in ARDS patients. Therefore, we concluded that TNF-α was quickly up-regulated and involved in the pathogenesis of CPB-induced ARDS via guiding primed neutrophils to pulmonary interstitium.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886234     DOI: 10.1007/s11684-012-0219-1

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  19 in total

Review 1.  Chemokines in lung injury: Thomas A. Neff Lecture.

Authors:  R M Strieter; S L Kunkel; M P Keane; T J Standiford
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

Review 2.  Neutrophil serine proteases: mediators of innate immune responses.

Authors:  Ulf Meyer-Hoffert; Oliver Wiedow
Journal:  Curr Opin Hematol       Date:  2011-01       Impact factor: 3.284

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 4.  Multiple roles for neutrophils in atherosclerosis.

Authors:  Oliver Soehnlein
Journal:  Circ Res       Date:  2012-03-16       Impact factor: 17.367

5.  Neutrophil beta2-integrin upregulation is blocked by a p38 MAP kinase inhibitor.

Authors:  R Tandon; R I Sha'afi; R S Thrall
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

Review 6.  Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry Coller; Claire M Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur S Slutsky; Kevin J Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin
Journal:  Am J Respir Crit Care Med       Date:  2003-04-01       Impact factor: 21.405

Review 7.  Acute lung injury and the acute respiratory distress syndrome: a clinical review.

Authors:  Arthur P Wheeler; Gordon R Bernard
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

8.  Behaviours of pulmonary sensory receptors during development of acute lung injury in the rabbit.

Authors:  Shuxin Lin; Jerome Walker; Ling Xu; David Gozal; Jerry Yu
Journal:  Exp Physiol       Date:  2007-03-28       Impact factor: 2.969

Review 9.  Biomarkers in acute lung injury: insights into the pathogenesis of acute lung injury.

Authors:  L J Mark Cross; Michael A Matthay
Journal:  Crit Care Clin       Date:  2011-04       Impact factor: 3.598

10.  TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation.

Authors:  Emmet E McGrath; Helen M Marriott; Allan Lawrie; Sheila E Francis; Ian Sabroe; Stephen A Renshaw; David H Dockrell; Moira K B Whyte
Journal:  J Leukoc Biol       Date:  2011-05-11       Impact factor: 4.962

View more
  6 in total

1.  Tumor necrosis factor-α plays an initiating role in extracorporeal circulation-induced acute lung injury.

Authors:  Tao Li; Nanfu Luo; Lei Du; Jing Zhou; Jie Zhang; Lina Gong; Nenggang Jiang
Journal:  Lung       Date:  2013-01-25       Impact factor: 2.584

2.  Is there a role of TNFR1 in acute lung injury cases associated with extracorporeal circulation?

Authors:  Yu Zhao; Chong-wei Zhang; Wen-jing Zhou; Jiao Chen; Nan-fu Luo; Li-na Gong; Lei Du; Jing Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

3.  Serum TNF-α levels in children with congenital heart disease undergoing cardiopulmonary bypass: A cohort study in China and a meta-analysis of the published literature.

Authors:  Shu-Tian Song; Chuan-Ming Bai; Ji-Wu Zhou
Journal:  J Clin Lab Anal       Date:  2016-12-13       Impact factor: 2.352

4.  Pulmonary artery perfusion with anti-tumor necrosis factor alpha antibody reduces cardiopulmonary bypass-induced inflammatory lung injury in a rabbit model.

Authors:  Yang Yu; Mingxin Gao; Haitao Li; Fan Zhang; Chengxiong Gu
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

5.  Aetiology, outcomes & predictors of mortality in acute respiratory distress syndrome from a tertiary care centre in north India.

Authors:  Surendra K Sharma; Anunay Gupta; Ashutosh Biswas; Abhishek Sharma; Atul Malhotra; K T Prasad; Sreenivas Vishnubhatla; Sajal Ajmani; Hridesh Mishra; Manish Soneja; Shobha Broor
Journal:  Indian J Med Res       Date:  2016-06       Impact factor: 2.375

6.  Ghrelin Pre-treatment Attenuates Local Oxidative Stress and End Organ Damage During Cardiopulmonary Bypass in Anesthetized Rats.

Authors:  Vijayakumar Sukumaran; Hirotsugu Tsuchimochi; Yutaka Fujii; Hiroshi Hosoda; Kenji Kangawa; Tsuyoshi Akiyama; Mikiyasu Shirai; Eisuke Tatsumi; James T Pearson
Journal:  Front Physiol       Date:  2018-03-09       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.